An exploratory open-label, investigator-initiated study to evaluate the efficacy and safety of combination sonidegib and buparlisib for advanced basal cell carcinomas. [electronic resource]
Producer: 20181126Description: 1011-1013.e3 p. digitalISSN:- 1097-6787
- Aged
- Aged, 80 and over
- Aminopyridines -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Biphenyl Compounds -- administration & dosage
- Carcinoma, Basal Cell -- drug therapy
- Cohort Studies
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Humans
- Male
- Maximum Tolerated Dose
- Middle Aged
- Morpholines -- administration & dosage
- Neoplasm Invasiveness -- pathology
- Neoplasm Staging
- Prognosis
- Prospective Studies
- Pyridines -- administration & dosage
- Skin Neoplasms -- drug therapy
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.